Skip to Content



PDF options:  View Fullscreen   Download PDF

PDF Transcript

Patient Information Leaflet

Telfast® 180mg film-coated tablets
(fexofenadine hydrochloride)
The name of your medicine is Telfast 180mg film-coated tablets,
but will be referred to as Telfast throughout the remainder of the
Read all of this leaflet carefully before you start taking this
medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or

This medicine has been prescribed for you only. Do not pass
it on to others. It may harm them, even if their signs of
illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this
leaflet. See section 4.
Your medicine is also available in the following strengths 30mg
and 120mg film-coated tablets.
What is in this leaflet
1. What Telfast is and what it is used for
2. What you need to know before you take Telfast
3. How to take Telfast
4. Possible side effects
5. How to store Telfast
6. Contents of the pack and other information
1. What Telfast is and what it is used for
Telfast contains fexofenadine hydrochloride, which is an
antihistamine. Telfast 180 mg is used in adults and adolescents
of 12 years and older to relieve the symptoms that occur with
long term allergic skin reactions (chronic idiopathic urticaria)
such as itching, swelling and rashes.
2. What you need to know before you take Telfast
Do not take Telfast

if you are allergic to fexofenadine or any of the other
ingredients of this medicine (listed in section 6)
Warnings and precautions
Talk to your doctor or pharmacist before taking Telfast if:

you have problems with your liver or kidneys

you have or ever had heart disease, since this kind of
medicine may lead to a fast or irregular heart beat

you are elderly
If any of these apply to you, or if you are not sure, tell your doctor
before taking Telfast.
Other medicines and Telfast
Tell your doctor or pharmacist if you are taking, have recently
taken or might take any other medicines. Indigestion remedies
containing aluminium and magnesium may affect the action of
Telfast by lowering the amount of medicinal product absorbed.
It is recommended that you leave about 2 hours between the
time that you take Telfast and your indigestion remedy.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any
Do not take Telfast if you are pregnant, unless necessary.
Telfast is not recommended during breast-feeding.

If you forget to take Telfast
Do not take a double dose to make up for a forgotten tablet.
Take the next dose at the usual time as prescribed by your
If you stop taking Telfast
Tell your doctor if you want to stop taking Telfast before you
have finished your course of treatment.
If you stop taking Telfast earlier than planned, your symptoms
may return.
If you have any further questions on the use of this medicine, ask
your doctor or pharmacist.
4. Possible side effects
4. Possible side effects
Like all medicines, this medicine can cause side effects, although
not everybody gets them.
Tell your doctor immediately and stop taking Telfast if you

swelling of the face, lips, tongue or throat and difficulty
breathing, as these may be signs of a serious allergic
Common side effects (may affect up to 1 in 10 people):



feeling sick (nausea)

Uncommon side effects (may affect up to 1 in 100 people):


Additional side effects (frequency not known: cannot be
estimated from the available data) which may occur are:

difficulty sleeping (insomnia)

sleeping disorders

bad dreams


fast or irregular heart beat


skin rash and itching


serious allergic reactions which can cause swelling of the
face, lips, tongue or throat, flushing, chest tightness, and
difficulty breathing.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side effects not listed in this
leaflet. You can also report side effects directly via the Yellow
Card Scheme at:
By reporting side effects you can help provide more information
on the safety of this medicine.
5. How to store Telfast
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on
the carton after EXP. The expiry date refers to the last day of that
This medicine does not require any special storage condition.
Do not throw away any medicines via wastewater or household
waste. Ask your pharmacist how to throw away medicines you no
longer use. These measures will help protect the environment.

Driving and using machines
Telfast is unlikely to affect your ability to drive or operate
machinery. However, you should check that these tablets do not
make you feel sleepy or dizzy before driving or operating
3. How to take Telfast
Always take this medicine exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure.
For adults and children aged 12 years and over
The recommended dose is one tablet (180 mg) daily.
Take your tablet with water before a meal.
This medicine starts to relieve your symptoms within 1 hour and
lasts for 24 hours.
If you take more Telfast than you should
If you take too many tablets, contact your doctor or the nearest
hospital emergency department immediately.
Symptoms of an overdose in adults are dizziness, drowsiness,
fatigue and dry mouth.


6. Contents of the pack and other information
Telfast 180 mg film-coated tablets are peach coloured, capsule
shaped tablets marked with “018” on one side and a scripted “e”
on the other.
Each tablet contains 180 mg of fexofenadine hydrochloride.
Also contains:
Tablet core: microcrystalline cellulose, pregelatinised maize
starch, croscarmellose sodium, magnesium stearate.
Film coating: hypromellose, povidone, titanium dioxide (E171),
colloidal anhydrous silica, macrogol 400 and iron oxide (E172).
Telfast is available in blister packs of 20 and 30 tablets.
Manufactured by: Sanofi-synthelabo Ltd Edgefield Avenue;
Fawdon Newcastle upon Tyne Tyne and Wear NE3 3TT United
Kingdom or Sanofi Winthrop Industrie 30-36 avenue Gustave
Eiffel 37100 Tours France or Sanofi Winthrop Industrie 56, Route
de Choisy-au-Bac 60205 Compiegne France. Procured from
within the EU. Product Licence Holder: Quadrant
Pharmaceuticals Ltd, Lynstock House, Lynstock Way, Lostock,
Bolton, BL6 4SA.
Repackaged by Maxearn Ltd, Bolton, BL6 4SA.
PL 20774/1444 Telfast 180mg film-coated tablets
Leaflet revision Date: 13 April 2017


Telfast is a registered trademark of Aventisub LLC

Blind or partially sighted?
Is this leaflet hard to see or read?
Contact Quadrant Pharmaceuticals
Ltd, Tel: 01204 473081


+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.